Literature DB >> 9568686

Bradykinin directly triggers GLUT4 translocation via an insulin-independent pathway.

K Kishi1, N Muromoto, Y Nakaya, I Miyata, A Hagi, H Hayashi, Y Ebina.   

Abstract

Physical exercise induces translocation of GLUT4 from an intracellular pool to the cell surface in skeletal muscles and increases glucose uptake via an insulin-independent pathway. However, the molecular mechanism remains to be identified. Some studies have suggested that bradykinin is locally released from contracting muscles and may be responsible for GLUT4 translocation and the increase of glucose transport in skeletal muscles. To determine whether bradykinin directly triggers GLUT4 translocation, we established L6 myotubes, 3T3-L1 adipocytes, and Chinese hamster ovary cells stably expressing c-myc epitope-tagged GLUT4 (GLUT4myc) and bradykinin B2 receptors. We found that bradykinin directly triggered GLUT4myc translocation and increased the rate of glucose uptake in a dose-dependent manner in these cells. The translocation with bradykinin occurred even after pretreatment with an islet-activating protein, wortmannin, and phorbol 12,13-dibutyrate. The signaling pathway does not seem to be mediated by Gi, phosphatidylinositol 3-kinase, or protein kinase C. It is insulin-independent and via trimeric G-protein Gq. Bradykinin is probably one of the factors responsible for exercise-stimulated glucose uptake in skeletal muscles.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9568686     DOI: 10.2337/diabetes.47.4.550

Source DB:  PubMed          Journal:  Diabetes        ISSN: 0012-1797            Impact factor:   9.461


  31 in total

1.  Gi-mediated translocation of GLUT4 is independent of p85/p110alpha and p110gamma phosphoinositide 3-kinases but might involve the activation of Akt kinase.

Authors:  L Wang; H Hayashi; K Kishi; L Huang; A Hagi; K Tamaoka; P T Hawkins; Y Ebina
Journal:  Biochem J       Date:  2000-02-01       Impact factor: 3.857

2.  G(alpha)11 signaling through ARF6 regulates F-actin mobilization and GLUT4 glucose transporter translocation to the plasma membrane.

Authors:  A Bose; A D Cherniack; S E Langille; S M Nicoloro; J M Buxton; J G Park; A Chawla; M P Czech
Journal:  Mol Cell Biol       Date:  2001-08       Impact factor: 4.272

3.  Genes and Elite Marathon Running Performance: A Systematic Review.

Authors:  Hannah J Moir; Rachael Kemp; Dirk Folkerts; Owen Spendiff; Cristina Pavlidis; Elizabeth Opara
Journal:  J Sports Sci Med       Date:  2019-08-01       Impact factor: 2.988

Review 4.  Acute effects of physical exercise in type 2 diabetes: A review.

Authors:  Ricardo Yukio Asano; Marcelo Magalhães Sales; Rodrigo Alberto Vieira Browne; José Fernando Vila Nova Moraes; Hélio José Coelho Júnior; Milton Rocha Moraes; Herbert Gustavo Simões
Journal:  World J Diabetes       Date:  2014-10-15

5.  Postexercise skeletal muscle glucose transport is normal in kininogen-deficient rats.

Authors:  George G Schweitzer; Gregory D Cartee
Journal:  Med Sci Sports Exerc       Date:  2011-07       Impact factor: 5.411

6.  AMPK enhances insulin-stimulated GLUT4 regulation via lowering membrane cholesterol.

Authors:  Kirk M Habegger; Nolan J Hoffman; Colin M Ridenour; Joseph T Brozinick; Jeffrey S Elmendorf
Journal:  Endocrinology       Date:  2012-03-20       Impact factor: 4.736

7.  The pleckstrin homology (PH) domain-interacting protein couples the insulin receptor substrate 1 PH domain to insulin signaling pathways leading to mitogenesis and GLUT4 translocation.

Authors:  Janet Farhang-Fallah; Varinder K Randhawa; Anjaruwee Nimnual; Amira Klip; Dafna Bar-Sagi; Maria Rozakis-Adcock
Journal:  Mol Cell Biol       Date:  2002-10       Impact factor: 4.272

8.  Ceramide 1-phosphate stimulates glucose uptake in macrophages.

Authors:  Alberto Ouro; Lide Arana; Patricia Gangoiti; Io-Guané Rivera; Marta Ordoñez; Miguel Trueba; Ravi S Lankalapalli; Robert Bittman; Antonio Gomez-Muñoz
Journal:  Cell Signal       Date:  2013-01-16       Impact factor: 4.315

9.  Comparative effects of a vasopeptidase inhibitor vs. an angiotensin converting enzyme inhibitor on cardiomyocyte apoptosis in rats with heart failure.

Authors:  Nathalie Lapointe; James N Tsoporis; Thomas G Parker; Charles Blais; Albert Adam; Dominique Rouleau; Graham Slaughter; Robert Clément; Christian E Deschepper; Jean L Rouleau
Journal:  Mol Cell Biochem       Date:  2003-12       Impact factor: 3.396

Review 10.  The sweeter side of ACE2: physiological evidence for a role in diabetes.

Authors:  Sharell M Bindom; Eric Lazartigues
Journal:  Mol Cell Endocrinol       Date:  2008-10-01       Impact factor: 4.102

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.